General MedicationsORALStandard
OXYBUTYNIN CHLORIDE
OXYBUTYNIN CHLORIDE
Standard Dose
5MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview OXYBUTYNIN CHLORIDE is listed in Drugs@FDA under application 214415 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient OXYBUTYNIN CHLORIDE Form and strength TABLET, EXTENDED RELEASE;ORAL - 5MG Sponsor RUBICON RESEARCH Submission history Latest submission status date: 2023-01-27 00:00:00.
Structured Monograph
Clinical summary
Approval overview OXYBUTYNIN CHLORIDE is listed in Drugs@FDA under application 214415 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient OXYBUTYNIN CHLORIDE Form and strength TABLET, EXTENDED RELEASE;ORAL - 5MG Sponsor RUBICON RESEARCH Submission history Latest submission status date: 2023-01-27 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.